Terms: = Skin cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
13359 results:
1. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Syc-Mazurek SB; Zhao-Fleming H; Guo Y; Tisavipat N; Chen JJ; Zekeridou A; Kournoutas I; Orme JJ; Block MS; Lucchinetti CF; Mustafa R; Flanagan EP
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200249. PubMed ID: 38696737
[TBL] [Abstract] [Full Text] [Related]
2. Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Sarin KY; Bradshaw M; O'Mara C; Shahryari J; Kincaid J; Kempers S; Tu JH; Dhawan S; DuBois J; Wilson D; Horwath P; de Souza MP; Powala C; Kochendoerfer GG; Plotkin SR; Webster GF; Le LQ
Sci Adv; 2024 May; 10(18):eadk4946. PubMed ID: 38691597
[TBL] [Abstract] [Full Text] [Related]
3. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic artery infusion chemotherapy with systemic capecitabine and camrelizumab for treating unresectable hilar cholangiocarcinoma: An initial investigation of efficacy and safety.
Li L; Liu S; Wang Q; Wang Y; Yu G
J Cancer Res Ther; 2024 Apr; 20(2):578-583. PubMed ID: 38687927
[TBL] [Abstract] [Full Text] [Related]
5. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment.
Meher RK; Mir SA; Singh K; Mukerjee N; Nayak B; Kumer A; Zughaibi TA; Khan MS; Tabrez S
J Cell Mol Med; 2024 May; 28(9):e18263. PubMed ID: 38685671
[TBL] [Abstract] [Full Text] [Related]
6. Management of post-Mohs surgical wounds with a hypothermically stored amniotic membrane: a case series.
Kapp D; Pfendler L
J Wound Care; 2024 May; 33(Sup5):S22-S27. PubMed ID: 38683816
[TBL] [Abstract] [Full Text] [Related]
7. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
8. Curing Stage IV Melanoma: Where Have We Been and Where Are We?
Chan PY; Corrie PG
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438654. PubMed ID: 38669609
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
10. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
11. Merkel cell carcinoma overlapping Bowen's disease: two cases report and literature review.
Chen X; Song X; Huang H; Zhang L; Song Z; Yang X; Lei S; Zhai Z
J Cancer Res Clin Oncol; 2024 Apr; 150(4):217. PubMed ID: 38668799
[TBL] [Abstract] [Full Text] [Related]
12. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
[TBL] [Abstract] [Full Text] [Related]
13. Rapid onset pembrolizumab-induced inflammatory arthritis diagnosed using musculoskeletal ultrasound.
Harnden K; Di Matteo A; Howell K; Mankia K
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38663895
[TBL] [Abstract] [Full Text] [Related]
14. Dermoscopic-Guided Shave Removal of Acquired Facial Melanocytic Nevi in Dark-skinned Individuals.
Rezk AF; Touni AA
Dermatol Surg; 2024 May; 50(5):434-438. PubMed ID: 38662517
[TBL] [Abstract] [Full Text] [Related]
15. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
[TBL] [Abstract] [Full Text] [Related]
16. skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract] [Full Text] [Related]
17. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract] [Full Text] [Related]
18. Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis.
Kaemmerer T; Guertler A; Clanner-Engelshofen BM; Fuchs C; French LE; Reinholz M
Acta Dermatovenerol Croat; 2023 Dec; 31(4):184-190. PubMed ID: 38651844
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
[TBL] [Abstract] [Full Text] [Related]
20. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
[TBL] [Abstract] [Full Text] [Related]
[Next]
